Antihormonal Cancer Therapies Market 2027 by Therapy type, Application and Geography | The Insight Partners

Antihormonal Cancer Therapies Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Therapy type (Neoadjuvant treatment, Adjuvant treatment); Application (Breast cancer, Prostate cancer, Ovarian cancer, Thyroid cancer, Others) and Geography

Report Code: TIPRE00008556 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Harmones are natural substances produced by glands in human body. These haromones are circulate throughout the body via blood stream. Harmones are used in cancer therapy. This involves exogenous administration of steroid harmones. These externally administered harmones inhibit the growth of cancerous cell. Harmone therapy is commonly used in treatment of breast and prostate cancer.

MARKET DYNAMICS

The Antihormonal Cancer Therapies Market is anticipated to grow in the forecast period owing to the rising incidence of cancer across the globe. Moreover, increasing healthcare expenditure and rising awareness among healthcare practitioner and patient of available alternative cancer therapy like target therapy, harmone therapy are anticipated to increase the demand for antiharmonal cancer therapies.

MARKET SCOPE

The "Global Antihormonal Cancer Therapies Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antihormonal Cancer Therapies Market with detailed market segmentation by therapy type, application and geography. The global Antihormonal Cancer Therapies Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Antihormonal Cancer Therapies Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Antihormonal Cancer Therapies Market is segmented on the basis of therapy type and application. Based on therapy type, the market is segmented into neoadjuvant treatment and adjuvant treatment. Based on application, the market is segmented into breast cancer, prostate cancer, ovarian cancer, thyroid cancer and others.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Antihormonal Cancer Therapies Marketbased on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antihormonal Cancer Therapies Marketby each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antihormonal Cancer Therapies Marketfrom both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antihormonal Cancer Therapies Marketin these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Antihormonal Cancer Therapies Marketas organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Antihormonal Cancer Therapies Market are anticipated to lucrative growth opportunities in the future with the rising demand for Antihormonal Cancer Therapies Market in the global market. Below mentioned is the list of few companies engaged in the Antihormonal Cancer Therapies market.

The report also includes the profiles of key Antihormonal Cancer Therapies Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Novartis International AG
- AstraZeneca Plc
- Merck and Co.
- Pfizer Inc
- QuatRx Pharmaceuticals
- Eli Lilly and Company
- Seattle Genetics
- Sanofi
- Bayer Healthcare
- Boehringer-Ingelheim

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antihormonal Cancer Therapies Market - By Therapy type
1.3.2 Antihormonal Cancer Therapies Market - By Application
1.3.3 Antihormonal Cancer Therapies Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTIHORMONAL CANCER THERAPIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTIHORMONAL CANCER THERAPIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. ANTIHORMONAL CANCER THERAPIES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIHORMONAL CANCER THERAPIES - GLOBAL MARKET OVERVIEW
6.2. ANTIHORMONAL CANCER THERAPIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTIHORMONAL CANCER THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. NEOADJUVANT TREATMENT
7.3.1. Overview
7.3.2. Neoadjuvant treatment Market Forecast and Analysis
7.4. ADJUVANT TREATMENT
7.4.1. Overview
7.4.2. Adjuvant treatment Market Forecast and Analysis
8. ANTIHORMONAL CANCER THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BREAST CANCER
8.3.1. Overview
8.3.2. Breast cancer Market Forecast and Analysis
8.4. PROSTATE CANCER
8.4.1. Overview
8.4.2. Prostate cancer Market Forecast and Analysis
8.5. OVARIAN CANCER
8.5.1. Overview
8.5.2. Ovarian cancer Market Forecast and Analysis
8.6. THYROID CANCER
8.6.1. Overview
8.6.2. Thyroid cancer Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. ANTIHORMONAL CANCER THERAPIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antihormonal Cancer Therapies Market Overview
9.1.2 North America Antihormonal Cancer Therapies Market Forecasts and Analysis
9.1.3 North America Antihormonal Cancer Therapies Market Forecasts and Analysis - By Therapy type
9.1.4 North America Antihormonal Cancer Therapies Market Forecasts and Analysis - By Application
9.1.5 North America Antihormonal Cancer Therapies Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antihormonal Cancer Therapies Market
9.1.5.1.1 United States Antihormonal Cancer Therapies Market by Therapy type
9.1.5.1.2 United States Antihormonal Cancer Therapies Market by Application
9.1.5.2 Canada Antihormonal Cancer Therapies Market
9.1.5.2.1 Canada Antihormonal Cancer Therapies Market by Therapy type
9.1.5.2.2 Canada Antihormonal Cancer Therapies Market by Application
9.1.5.3 Mexico Antihormonal Cancer Therapies Market
9.1.5.3.1 Mexico Antihormonal Cancer Therapies Market by Therapy type
9.1.5.3.2 Mexico Antihormonal Cancer Therapies Market by Application
9.2. EUROPE
9.2.1 Europe Antihormonal Cancer Therapies Market Overview
9.2.2 Europe Antihormonal Cancer Therapies Market Forecasts and Analysis
9.2.3 Europe Antihormonal Cancer Therapies Market Forecasts and Analysis - By Therapy type
9.2.4 Europe Antihormonal Cancer Therapies Market Forecasts and Analysis - By Application
9.2.5 Europe Antihormonal Cancer Therapies Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antihormonal Cancer Therapies Market
9.2.5.1.1 Germany Antihormonal Cancer Therapies Market by Therapy type
9.2.5.1.2 Germany Antihormonal Cancer Therapies Market by Application
9.2.5.2 France Antihormonal Cancer Therapies Market
9.2.5.2.1 France Antihormonal Cancer Therapies Market by Therapy type
9.2.5.2.2 France Antihormonal Cancer Therapies Market by Application
9.2.5.3 Italy Antihormonal Cancer Therapies Market
9.2.5.3.1 Italy Antihormonal Cancer Therapies Market by Therapy type
9.2.5.3.2 Italy Antihormonal Cancer Therapies Market by Application
9.2.5.4 Spain Antihormonal Cancer Therapies Market
9.2.5.4.1 Spain Antihormonal Cancer Therapies Market by Therapy type
9.2.5.4.2 Spain Antihormonal Cancer Therapies Market by Application
9.2.5.5 United Kingdom Antihormonal Cancer Therapies Market
9.2.5.5.1 United Kingdom Antihormonal Cancer Therapies Market by Therapy type
9.2.5.5.2 United Kingdom Antihormonal Cancer Therapies Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antihormonal Cancer Therapies Market Overview
9.3.2 Asia-Pacific Antihormonal Cancer Therapies Market Forecasts and Analysis
9.3.3 Asia-Pacific Antihormonal Cancer Therapies Market Forecasts and Analysis - By Therapy type
9.3.4 Asia-Pacific Antihormonal Cancer Therapies Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Antihormonal Cancer Therapies Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antihormonal Cancer Therapies Market
9.3.5.1.1 Australia Antihormonal Cancer Therapies Market by Therapy type
9.3.5.1.2 Australia Antihormonal Cancer Therapies Market by Application
9.3.5.2 China Antihormonal Cancer Therapies Market
9.3.5.2.1 China Antihormonal Cancer Therapies Market by Therapy type
9.3.5.2.2 China Antihormonal Cancer Therapies Market by Application
9.3.5.3 India Antihormonal Cancer Therapies Market
9.3.5.3.1 India Antihormonal Cancer Therapies Market by Therapy type
9.3.5.3.2 India Antihormonal Cancer Therapies Market by Application
9.3.5.4 Japan Antihormonal Cancer Therapies Market
9.3.5.4.1 Japan Antihormonal Cancer Therapies Market by Therapy type
9.3.5.4.2 Japan Antihormonal Cancer Therapies Market by Application
9.3.5.5 South Korea Antihormonal Cancer Therapies Market
9.3.5.5.1 South Korea Antihormonal Cancer Therapies Market by Therapy type
9.3.5.5.2 South Korea Antihormonal Cancer Therapies Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antihormonal Cancer Therapies Market Overview
9.4.2 Middle East and Africa Antihormonal Cancer Therapies Market Forecasts and Analysis
9.4.3 Middle East and Africa Antihormonal Cancer Therapies Market Forecasts and Analysis - By Therapy type
9.4.4 Middle East and Africa Antihormonal Cancer Therapies Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Antihormonal Cancer Therapies Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antihormonal Cancer Therapies Market
9.4.5.1.1 South Africa Antihormonal Cancer Therapies Market by Therapy type
9.4.5.1.2 South Africa Antihormonal Cancer Therapies Market by Application
9.4.5.2 Saudi Arabia Antihormonal Cancer Therapies Market
9.4.5.2.1 Saudi Arabia Antihormonal Cancer Therapies Market by Therapy type
9.4.5.2.2 Saudi Arabia Antihormonal Cancer Therapies Market by Application
9.4.5.3 U.A.E Antihormonal Cancer Therapies Market
9.4.5.3.1 U.A.E Antihormonal Cancer Therapies Market by Therapy type
9.4.5.3.2 U.A.E Antihormonal Cancer Therapies Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antihormonal Cancer Therapies Market Overview
9.5.2 South and Central America Antihormonal Cancer Therapies Market Forecasts and Analysis
9.5.3 South and Central America Antihormonal Cancer Therapies Market Forecasts and Analysis - By Therapy type
9.5.4 South and Central America Antihormonal Cancer Therapies Market Forecasts and Analysis - By Application
9.5.5 South and Central America Antihormonal Cancer Therapies Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antihormonal Cancer Therapies Market
9.5.5.1.1 Brazil Antihormonal Cancer Therapies Market by Therapy type
9.5.5.1.2 Brazil Antihormonal Cancer Therapies Market by Application
9.5.5.2 Argentina Antihormonal Cancer Therapies Market
9.5.5.2.1 Argentina Antihormonal Cancer Therapies Market by Therapy type
9.5.5.2.2 Argentina Antihormonal Cancer Therapies Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANTIHORMONAL CANCER THERAPIES MARKET, KEY COMPANY PROFILES
11.1. NOVARTIS INTERNATIONAL AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRAZENECA PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK AND CO.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PFIZER INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. QUATRX PHARMACEUTICALS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ELI LILLY AND COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SEATTLE GENETICS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANOFI
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BAYER HEALTHCARE
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BOEHRINGER-INGELHEIM
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis International AG
2. AstraZeneca Plc
3. Merck and Co.
4. Pfizer Inc
5. QuatRx Pharmaceuticals
6. Eli Lilly and Company
7. Seattle Genetics
8. Sanofi
9. Bayer Healthcare
10. Boehringer-Ingelheim
TIPRE00008556
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking